152 related articles for article (PubMed ID: 15854545)
1. [Arsenic treatment for leukemia: new model of human cancer target treatment].
Zhao WW; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
[No Abstract] [Full Text] [Related]
2. Old, new drugs and new, new drugs for the new millennium.
Scheinberg DA
Curr Oncol Rep; 2000 Mar; 2(2):112-3. PubMed ID: 11122831
[No Abstract] [Full Text] [Related]
3. Chemotherapy-free treatment of acute promyelocytic leukemia.
Ravandi F
Clin Adv Hematol Oncol; 2015 Aug; 13(8):498-500. PubMed ID: 26351810
[No Abstract] [Full Text] [Related]
4. Newly diagnosed acute promyelocytic leukemia: arsenic moves front and center.
Estey EH; Hutchinson F
J Clin Oncol; 2011 Jul; 29(20):2743-6. PubMed ID: 21646610
[No Abstract] [Full Text] [Related]
5. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
Ma J
Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
[No Abstract] [Full Text] [Related]
6. How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
Koehler M; Fischer T
J Clin Oncol; 2015 Mar; 33(9):1090-1. PubMed ID: 25691667
[No Abstract] [Full Text] [Related]
7. Reply to M. Koehler et al.
Efficace F; Cottone F; Lo-Coco F
J Clin Oncol; 2015 Mar; 33(9):1091-2. PubMed ID: 25691680
[No Abstract] [Full Text] [Related]
8. ATRA plus arsenic gets another "A" in APL.
Park JH
Blood; 2012 Aug; 120(8):1535-6. PubMed ID: 22918418
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute promyelocytic leukemia.
Miura Y; Suyama K; Takano T
N Engl J Med; 2013 Oct; 369(15):1471-2. PubMed ID: 24106949
[No Abstract] [Full Text] [Related]
10. Treatment of acute promyelocytic leukemia.
Lo-Coco F; Orlando SM; Platzbecker U
N Engl J Med; 2013 Oct; 369(15):1472. PubMed ID: 24106948
[No Abstract] [Full Text] [Related]
11. Targeting agents alone to cure acute promyelocytic leukemia.
Chen SJ; Chen Z
N Engl J Med; 2013 Jul; 369(2):186-7. PubMed ID: 23841735
[No Abstract] [Full Text] [Related]
12. Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.
Breccia M; Cicconi L; Minotti C; Latagliata R; Giannì L; Lo-Coco F
Haematologica; 2011 Sep; 96(9):1390-1. PubMed ID: 21659361
[No Abstract] [Full Text] [Related]
13. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia.
Look AT
J Natl Cancer Inst; 1998 Jan; 90(2):86-8. PubMed ID: 9450562
[No Abstract] [Full Text] [Related]
14. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
Sasaki M; Sugimoto K; Isobe Y; Oshimi K
Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
[No Abstract] [Full Text] [Related]
15. Leukemia, an effective model for chemical biology and target therapy.
Chen GQ; Wang LS; Wu YL; Yu Y
Acta Pharmacol Sin; 2007 Sep; 28(9):1316-24. PubMed ID: 17723165
[TBL] [Abstract][Full Text] [Related]
16. Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
Ravandi F; Kantarjian H
Lancet Oncol; 2015 Oct; 16(13):1274-5. PubMed ID: 26384240
[No Abstract] [Full Text] [Related]
17. Treatment of acute promyelocytic leukemia in children: arsenic or ATRA.
Ravindranath Y; Gregory J; Feusner J
Leukemia; 2004 Oct; 18(10):1576-7. PubMed ID: 15356650
[No Abstract] [Full Text] [Related]
18. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
Haanen C; Vermes I
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
Young CS; Clarke KM; Mills KI
EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
[No Abstract] [Full Text] [Related]
20. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
